Boehringer and AbbVie in Cancer-Partnership Negotiations?
Mar 01, 2016
Bloomberg
Boehringer Ingelheim and Abbvie are reportedly negotiating a partnership that could help the companies expand their cancer treatment businesses, according to a Bloomberg article.
The talks are advanced and an agreement may be announced as early as this week, unnamed sources said. The oncology alliance could possibly be worth multi-billions of dollars.
Read the Bloomberg story
Show Comments
Join the discussion
We welcome your thoughtful comments.
All comments will display your user name.
Comments
No one has commented on this page yet.
RSS feed for comments on this page | RSS feed for all comments